JP2008513474A - 下痢を予防するかまたは治療する方法及び組成物 - Google Patents
下痢を予防するかまたは治療する方法及び組成物 Download PDFInfo
- Publication number
- JP2008513474A JP2008513474A JP2007532483A JP2007532483A JP2008513474A JP 2008513474 A JP2008513474 A JP 2008513474A JP 2007532483 A JP2007532483 A JP 2007532483A JP 2007532483 A JP2007532483 A JP 2007532483A JP 2008513474 A JP2008513474 A JP 2008513474A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- microbial
- gum
- diarrhea
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims description 79
- 230000000813 microbial effect Effects 0.000 claims abstract description 67
- 229920002444 Exopolysaccharide Polymers 0.000 claims abstract description 66
- 241000124008 Mammalia Species 0.000 claims abstract description 31
- 229920002148 Gellan gum Polymers 0.000 claims abstract description 25
- 235000010492 gellan gum Nutrition 0.000 claims abstract description 21
- 239000000216 gellan gum Substances 0.000 claims abstract description 21
- 235000013305 food Nutrition 0.000 claims description 26
- 239000006041 probiotic Substances 0.000 claims description 21
- 235000018291 probiotics Nutrition 0.000 claims description 21
- 235000005911 diet Nutrition 0.000 claims description 18
- 230000037213 diet Effects 0.000 claims description 18
- 239000003793 antidiarrheal agent Substances 0.000 claims description 16
- 235000013406 prebiotics Nutrition 0.000 claims description 15
- 235000012041 food component Nutrition 0.000 claims description 14
- 239000005417 food ingredient Substances 0.000 claims description 13
- 229940125714 antidiarrheal agent Drugs 0.000 claims description 11
- 235000015872 dietary supplement Nutrition 0.000 claims description 11
- 150000004676 glycans Chemical class 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 230000002496 gastric effect Effects 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 8
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 229920002558 Curdlan Polymers 0.000 claims description 6
- 239000001879 Curdlan Substances 0.000 claims description 6
- 235000019316 curdlan Nutrition 0.000 claims description 6
- 229940078035 curdlan Drugs 0.000 claims description 6
- 230000003449 preventive effect Effects 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- 230000000007 visual effect Effects 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- PNNNRSAQSRJVSB-UHFFFAOYSA-N 2,3,4,5-tetrahydroxyhexanal Chemical compound CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 230000008901 benefit Effects 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 4
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 229920002749 Bacterial cellulose Polymers 0.000 claims description 3
- 229920002307 Dextran Polymers 0.000 claims description 3
- 229920001218 Pullulan Polymers 0.000 claims description 3
- 239000004373 Pullulan Substances 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 3
- 229920002305 Schizophyllan Polymers 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 239000005016 bacterial cellulose Substances 0.000 claims description 3
- 230000037396 body weight Effects 0.000 claims description 3
- 229920000591 gum Polymers 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 235000019423 pullulan Nutrition 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 235000013365 dairy product Nutrition 0.000 claims description 2
- 235000013601 eggs Nutrition 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims 2
- 239000007894 caplet Substances 0.000 claims 1
- 235000013622 meat product Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 241001465754 Metazoa Species 0.000 description 24
- 241000282326 Felis catus Species 0.000 description 17
- 235000012054 meals Nutrition 0.000 description 11
- 241000282472 Canis lupus familiaris Species 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 235000013882 gravy Nutrition 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 230000013872 defecation Effects 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 241000186000 Bifidobacterium Species 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 235000020940 control diet Nutrition 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000000529 probiotic effect Effects 0.000 description 4
- 235000021195 test diet Nutrition 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000282324 Felis Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000736131 Sphingomonas Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
- 229960004618 prednisone Drugs 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- XRHVZWWRFMCBAZ-UHFFFAOYSA-L Endothal-disodium Chemical compound [Na+].[Na+].C1CC2C(C([O-])=O)C(C(=O)[O-])C1O2 XRHVZWWRFMCBAZ-UHFFFAOYSA-L 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- LYPFDBRUNKHDGX-SOGSVHMOSA-N N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 Chemical compound N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 LYPFDBRUNKHDGX-SOGSVHMOSA-N 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000736110 Sphingomonas paucimobilis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 229960004192 diphenoxylate Drugs 0.000 description 1
- HYPPXZBJBPSRLK-UHFFFAOYSA-N diphenoxylate Chemical compound C1CC(C(=O)OCC)(C=2C=CC=CC=2)CCN1CCC(C#N)(C=1C=CC=CC=1)C1=CC=CC=C1 HYPPXZBJBPSRLK-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229960001571 loperamide Drugs 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229940050957 opium tincture Drugs 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 229940045258 pancrelipase Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960002197 temoporfin Drugs 0.000 description 1
- 150000004044 tetrasaccharides Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/719—Pullulans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/723—Xanthans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L25/00—Baseband systems
- H04L25/02—Details ; arrangements for supplying electrical power along data transmission lines
- H04L25/03—Shaping networks in transmitter or receiver, e.g. adaptive shaping networks
- H04L25/03828—Arrangements for spectral shaping; Arrangements for providing signals with specified spectral properties
- H04L25/03834—Arrangements for spectral shaping; Arrangements for providing signals with specified spectral properties using pulse shaping
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L27/00—Modulated-carrier systems
- H04L27/18—Phase-modulated carrier systems, i.e. using phase-shift keying
- H04L27/20—Modulator circuits; Transmitter circuits
- H04L27/2003—Modulator circuits; Transmitter circuits for continuous phase modulation
- H04L27/2007—Modulator circuits; Transmitter circuits for continuous phase modulation in which the phase change within each symbol period is constrained
- H04L27/2017—Modulator circuits; Transmitter circuits for continuous phase modulation in which the phase change within each symbol period is constrained in which the phase changes are non-linear, e.g. generalized and Gaussian minimum shift keying, tamed frequency modulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Physics & Mathematics (AREA)
- Computer Networks & Wireless Communication (AREA)
- Signal Processing (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Nonlinear Science (AREA)
- Power Engineering (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/942,397 US8685943B2 (en) | 2003-03-12 | 2004-09-16 | Methods for reducing diarrhea in a companion animal |
| PCT/US2005/033077 WO2006032005A2 (en) | 2004-09-16 | 2005-09-16 | Method and composition for preventing or treating diarrhea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008513474A true JP2008513474A (ja) | 2008-05-01 |
| JP2008513474A5 JP2008513474A5 (enExample) | 2008-10-30 |
Family
ID=36060717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007532483A Pending JP2008513474A (ja) | 2004-09-16 | 2005-09-16 | 下痢を予防するかまたは治療する方法及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US8685943B2 (enExample) |
| EP (1) | EP1796728A4 (enExample) |
| JP (1) | JP2008513474A (enExample) |
| CN (2) | CN101060861B (enExample) |
| AU (1) | AU2005284784B2 (enExample) |
| BR (1) | BRPI0515376A (enExample) |
| CA (1) | CA2581020C (enExample) |
| RU (2) | RU2563137C2 (enExample) |
| WO (1) | WO2006032005A2 (enExample) |
| ZA (1) | ZA200703100B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102271531A (zh) * | 2009-01-06 | 2011-12-07 | 雀巢产品技术援助有限公司 | 果冻食物组合物中的块状物 |
| JP5554350B2 (ja) * | 2009-03-11 | 2014-07-23 | ネステク ソシエテ アノニム | 具材入り肉汁食品組成物 |
| EP2588544A1 (fr) * | 2010-07-02 | 2013-05-08 | Ifremer (Institut Français De Recherche Pour L'Exploitation De La Mer) | Exopolysaccharides pour la prévention et la lutte contre la formation de biofilms |
| EP2797426A1 (en) * | 2011-12-29 | 2014-11-05 | Hill's Pet Nutrition, Inc. | Compositions and methods for modifying gastrointestinal flora |
| JP6452616B2 (ja) * | 2012-12-04 | 2019-01-16 | ネステク ソシエテ アノニム | 擬似ローフ食品組成物 |
| GB201519854D0 (en) * | 2015-11-10 | 2015-12-23 | Mars Inc | Pet food |
| CN107296815A (zh) * | 2017-06-29 | 2017-10-27 | 中国人民解放军第二军医大学 | 酵母多糖在制备防护急性放射性骨髓损伤药物中的应用 |
| US11622974B2 (en) | 2019-01-18 | 2023-04-11 | C.P. Kelco U.S., Inc. | Prebiotic composition and its use |
| RU2740380C1 (ru) * | 2019-12-24 | 2021-01-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Биоинженерная конструкция на основе бактериального альгината и пробиотических бактерий и способ ее получения |
| TWI840668B (zh) * | 2021-05-13 | 2024-05-01 | 陳昭誠 | 由β-1-4-葡聚醣形成之纖維於製備用於治療腸躁症之組成物之用途 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02289520A (ja) * | 1989-02-09 | 1990-11-29 | Hayashibara Biochem Lab Inc | ビフィズス菌増殖促進剤 |
| JP2004523241A (ja) * | 2001-03-07 | 2004-08-05 | プロバイオニック コーポレイション | プロバイオティクスとして有用な新規ラクトバチルス・ロイテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ） |
| JP2006519863A (ja) * | 2003-03-12 | 2006-08-31 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 下痢を予防するかまたは低減する方法及び組成物 |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1501484A (en) * | 1975-10-24 | 1978-02-15 | Tate & Lyle Ltd | Icing mixture |
| US4410551A (en) * | 1980-05-15 | 1983-10-18 | Ralston Purina Company | Gravy forming intermediate moisture pet food |
| GB8512345D0 (en) * | 1985-05-15 | 1985-06-19 | Scras | Anti-diarrhea compositions |
| US4647470A (en) * | 1985-11-27 | 1987-03-03 | Merck & Co., Inc. | Low-acetyl gellan gum blends |
| US4822626A (en) * | 1987-01-05 | 1989-04-18 | Nabisco Brands, Inc. | Coated canine biscuits |
| GB8710704D0 (en) | 1987-05-06 | 1987-06-10 | Mars G B Ltd | Edible gels |
| EP0291228B1 (en) | 1987-05-14 | 1991-08-28 | Merck & Co. Inc. | Gellan gum/starch blends |
| JPH01193388A (ja) | 1987-10-09 | 1989-08-03 | Agency Of Ind Science & Technol | リオトロピック液晶セル |
| JP2769707B2 (ja) | 1988-11-28 | 1998-06-25 | 大洋香料株式会社 | 透明水性ゲル状芳香剤組成物 |
| DE69112260T2 (de) | 1990-04-23 | 1996-04-11 | Monsanto Co | Gellan-Gummi-Fasern. |
| IT1248934B (it) | 1990-06-01 | 1995-02-11 | Fidia Spa | Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle |
| US5079024A (en) * | 1990-09-25 | 1992-01-07 | Kraft General Foods, Inc. | Method of manufacture of a non-fat cream cheese product |
| US5158800A (en) * | 1991-10-08 | 1992-10-27 | Merck & Co., Inc. | Non-sticky, fat-containing confection |
| JPH0690707A (ja) * | 1992-01-06 | 1994-04-05 | Asahi Chem Ind Co Ltd | 緩下作用の改善された食物繊維組成物 |
| US5292534A (en) * | 1992-03-25 | 1994-03-08 | Valentine Enterprises, Inc. | Sustained release composition and method utilizing xanthan gum and an active ingredient |
| US5419283A (en) * | 1992-04-08 | 1995-05-30 | Ciuffo Gatto S.R.L. | Animal chew toy of starch material and degradable ethylene copolymer |
| US5380522A (en) * | 1992-08-11 | 1995-01-10 | Day; Charles E. | Method for treatment of irritable bowel syndrome |
| US5372829A (en) * | 1993-01-15 | 1994-12-13 | Merck & Co., Inc. | Process for preparing low-fat fried food |
| CA2125914A1 (en) | 1993-06-25 | 1994-12-26 | Pharmacia Corporation | Oil-coated microparticulated gellan gum |
| US5339771A (en) * | 1993-09-15 | 1994-08-23 | Axelrod Herbert R | Animal chew toy containing animal meal |
| US5571545A (en) * | 1994-02-22 | 1996-11-05 | Fuji Oil Company, Limited | Hamburger type food material and process of making it |
| US5616569A (en) * | 1994-03-28 | 1997-04-01 | The Iams Company | Pet food product containing fermentable fibers and process for treating gastrointestinal disorders |
| US5534286A (en) | 1994-06-01 | 1996-07-09 | Monsanto Company | No-fat gellan gum spread |
| US5456937A (en) * | 1994-06-24 | 1995-10-10 | Chalupa; William F. | Gellan gum flavor beads |
| US5596084A (en) * | 1994-10-05 | 1997-01-21 | Monsanto Company | Alginate gels |
| JPH08157377A (ja) * | 1994-12-02 | 1996-06-18 | Nippon Oil Co Ltd | 家畜等の下痢予防・治療剤 |
| JP3836893B2 (ja) * | 1995-01-24 | 2006-10-25 | アボットジャパン株式会社 | ポリカルボフィルカルシウム含有製剤 |
| US5827526A (en) * | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
| JPH09172980A (ja) * | 1995-12-28 | 1997-07-08 | Ajinomoto Co Inc | 新規リン酸アミノ酸複合塩及び水溶性高分子を含有する反すう動物用飼料添加組成物 |
| JP3955112B2 (ja) | 1996-01-10 | 2007-08-08 | エステー化学株式会社 | ゲル状脱臭剤 |
| JPH09194393A (ja) * | 1996-01-22 | 1997-07-29 | Meiji Milk Prod Co Ltd | 免疫寛容を誘導する方法、免疫寛容誘導食品キットおよび免疫寛容誘導剤キット |
| JPH09201170A (ja) | 1996-01-24 | 1997-08-05 | Dainippon Pharmaceut Co Ltd | ジェランガム含有α化澱粉 |
| JPH09275973A (ja) | 1996-04-12 | 1997-10-28 | Suzuki Motor Corp | 微生物用培地 |
| GB2314840B (en) | 1996-06-28 | 2000-09-06 | Johnson & Johnson Medical | Oxidized oligosaccharides and pharmaceutical compositions |
| JPH1067625A (ja) | 1996-08-22 | 1998-03-10 | Lion Corp | 口腔用組成物 |
| JPH10179050A (ja) | 1996-12-27 | 1998-07-07 | Sanei Gen F F I Inc | ネイティブジェランガムを含有する食品 |
| US6458404B1 (en) * | 1996-08-27 | 2002-10-01 | San-Ei Gen F.F.I., Inc. | Dehydrated gel composition from hydrated isolated acetylated gellan gum |
| US5869118A (en) * | 1996-11-13 | 1999-02-09 | Abbott Laboratories | Gellan gum to improve physical stability of liquid nutritional products |
| US5895804A (en) * | 1997-10-27 | 1999-04-20 | National Starch And Chemical Investment Holding Corporation | Thermosetting polysaccharides |
| JP3874560B2 (ja) | 1998-01-09 | 2007-01-31 | 旭化成ケミカルズ株式会社 | 微細セルロース含有複合物 |
| TW408153B (en) | 1998-01-09 | 2000-10-11 | Asahi Chemical Ind | Cellulose-containing composite, process for its preparation and use thereof |
| JP2002517568A (ja) | 1998-06-10 | 2002-06-18 | モンサント・ピーエルシー | 改質ゲランガム組成物、その調製工程およびその用途 |
| JP3633942B2 (ja) | 1998-09-09 | 2005-03-30 | キユーピー株式会社 | 嘔吐予防食品 |
| US6242035B1 (en) | 1998-11-23 | 2001-06-05 | Cp Kelco U.S., Inc. | Reduced molecular weight native gellan gum |
| NL1013175C2 (nl) | 1999-09-29 | 2001-03-30 | Nutricia Nv | Voedingssamenstellingen die niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions. |
| US6280779B1 (en) * | 1999-12-28 | 2001-08-28 | Colgate-Palmolive Company | Pet food for maintaining normal bowel health |
| US6410079B2 (en) * | 1999-12-28 | 2002-06-25 | Hill's Pet Nutrition, Inc. | High meat pet food compositions |
| US6426195B1 (en) * | 2000-03-28 | 2002-07-30 | Biogenex Lab | Method for silver staining a pathologic sample |
| JP2001269125A (ja) | 2000-03-29 | 2001-10-02 | Nihon Nosan Kogyo Kk | 豚用飼料 |
| EP1250851A1 (en) * | 2001-04-18 | 2002-10-23 | Societe Des Produits Nestle S.A. | Pet food composition containing semi-refined gelling agent |
| NZ515869A (en) | 2001-11-30 | 2003-09-26 | Med Chem Ingredients Ltd | Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides |
| JP2003210075A (ja) * | 2002-01-21 | 2003-07-29 | Nippon Flour Mills Co Ltd | 釣用疑似餌、その製造方法及び釣用疑似餌の製造用キット |
| GB0203431D0 (en) | 2002-02-13 | 2002-04-03 | Mars Inc | Gel |
| JP2003259817A (ja) | 2002-03-08 | 2003-09-16 | Takeo Co Ltd | ペット用冷菓組成物、それを用いたペット用冷菓およびペット用冷菓の製造方法 |
| CN1395938A (zh) * | 2002-09-03 | 2003-02-12 | 林斌 | 一种含低聚果糖的兽用口服液制剂 |
| US7455869B2 (en) * | 2002-12-19 | 2008-11-25 | San-Ei Gen F.F.I., Inc. | Composition for preparing artificial fruit flesh and food product containing the same |
| US20040168951A1 (en) | 2003-02-27 | 2004-09-02 | Mackie Robert W. | Method and system for self administration of medications |
| US20050004071A1 (en) * | 2003-04-21 | 2005-01-06 | Comper Wayne D. | Charged polysaccharides resistant to lysosomal degradation during kidney filtration and renal passage and their use to treat or prevent infection by coronaviruses |
| CA2530843A1 (en) | 2003-07-01 | 2005-01-20 | Todd Maibach | Film comprising therapeutic agents |
| US20050119222A1 (en) | 2003-12-01 | 2005-06-02 | The Iams Company | Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use |
-
2004
- 2004-09-16 US US10/942,397 patent/US8685943B2/en not_active Expired - Lifetime
-
2005
- 2005-09-16 RU RU2010135601/15A patent/RU2563137C2/ru not_active IP Right Cessation
- 2005-09-16 JP JP2007532483A patent/JP2008513474A/ja active Pending
- 2005-09-16 CN CN200580039219.1A patent/CN101060861B/zh not_active Expired - Fee Related
- 2005-09-16 CN CN201610289207.4A patent/CN105878267A/zh active Pending
- 2005-09-16 BR BRPI0515376-0A patent/BRPI0515376A/pt not_active IP Right Cessation
- 2005-09-16 CA CA2581020A patent/CA2581020C/en not_active Expired - Fee Related
- 2005-09-16 RU RU2007114054/14A patent/RU2007114054A/ru not_active Application Discontinuation
- 2005-09-16 WO PCT/US2005/033077 patent/WO2006032005A2/en not_active Ceased
- 2005-09-16 AU AU2005284784A patent/AU2005284784B2/en not_active Ceased
- 2005-09-16 EP EP05797991A patent/EP1796728A4/en not_active Ceased
-
2007
- 2007-04-16 ZA ZA2007/03100A patent/ZA200703100B/en unknown
-
2008
- 2008-03-17 US US12/049,546 patent/US8563029B2/en not_active Expired - Fee Related
-
2014
- 2014-02-24 US US14/188,054 patent/US9028861B2/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02289520A (ja) * | 1989-02-09 | 1990-11-29 | Hayashibara Biochem Lab Inc | ビフィズス菌増殖促進剤 |
| JP2004523241A (ja) * | 2001-03-07 | 2004-08-05 | プロバイオニック コーポレイション | プロバイオティクスとして有用な新規ラクトバチルス・ロイテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ） |
| JP2006519863A (ja) * | 2003-03-12 | 2006-08-31 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 下痢を予防するかまたは低減する方法及び組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| US8685943B2 (en) | 2014-04-01 |
| BRPI0515376A (pt) | 2008-07-22 |
| CN101060861A (zh) | 2007-10-24 |
| CN101060861B (zh) | 2016-06-01 |
| EP1796728A4 (en) | 2008-07-23 |
| US20080160164A1 (en) | 2008-07-03 |
| RU2563137C2 (ru) | 2015-09-20 |
| CA2581020A1 (en) | 2006-03-23 |
| AU2005284784A1 (en) | 2006-03-23 |
| WO2006032005A2 (en) | 2006-03-23 |
| ZA200703100B (en) | 2015-09-30 |
| AU2005284784B2 (en) | 2010-12-16 |
| RU2007114054A (ru) | 2008-10-27 |
| CN105878267A (zh) | 2016-08-24 |
| RU2010135601A (ru) | 2012-02-27 |
| US20050042260A1 (en) | 2005-02-24 |
| US8563029B2 (en) | 2013-10-22 |
| US20140171386A1 (en) | 2014-06-19 |
| EP1796728A2 (en) | 2007-06-20 |
| WO2006032005A3 (en) | 2006-10-19 |
| US9028861B2 (en) | 2015-05-12 |
| CA2581020C (en) | 2016-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2561679C2 (ru) | Способы и композиции для улучшения состояния желудочно-кишечного тракта у животных | |
| US20090324761A1 (en) | Methods And Compositions for Improving Gastrointestinal Health | |
| RU2585851C2 (ru) | Композиции и способы модификации желудочно-кишечной флоры | |
| US9028861B2 (en) | Method and composition to reduce diarrhea in a companion animal | |
| JP5329229B2 (ja) | 糞便の質および／または排便回数を改変するための方法 | |
| JP5004580B2 (ja) | 下痢を予防するかまたは低減する方法及び組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080908 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080908 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110912 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111026 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120125 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120201 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120601 |